Oct. 30, 2009 (Business Wire) -- PicksThatMove is pleased to bring investors special situation stocks which have a high potential for price appreciation. These companies have interesting business models and they have to execute on the business development level to bring value to shareholders. Some of our past picks had soared over 200%. To view some of our profiled stocks, please visit our website at www.picksthatmove.com.
At PicksThatMove, our team scours the technical and financials of hundreds of companies to identify those stocks showing the greatest potential for growth.
The investment opinions offered below and in this press release are provided by Nick Hunter, RIA, of PicksThatMove.com
Cardium Therapeutics Inc. (AMEX: CXM), $0.69, -$0.05, -6.78%, is a company focused on the acquisition and development of new and innovative biomedical product opportunities and businesses. The company is actively trading and making gains with over 3 million shares traded today. The last release confirms that the company completed its $6 million common stock offering to selected investors. This transaction brings in profit of $5.5 million. The complete details have been filed by the company and are available on the SEC website.
NuLoch Resources Inc. (TSX-V: NLR.A), $0.69, +$0.039, 4.55%, the company is making gains today of 6.06% with 3 million shares trading hands compared to a volume of 124,000 yesterday. NuLoch Resources is engaged in the exploration and development business of petroleum and natural gas in Alberta. NLRA confirmed two new additions to its team, namely Gary Browne as Vice-President, directing the corporate development activities and Nathan Laviolette as Senior Landman, with responsibilities for development of company’s interests in Saskatchewan. Furthermore, the Board of Directors gave their approval for a grant of stock options to directors, officers and employees of the Company to purchase an aggregate of 3,405,000 Class A common shares at $0.70 per common share pursuant to the Company's stock option plan.
Power 3 Medical Products Inc. (OTCBB: PWRM), $0.079, +$0.0265, 50.48%, is a company involved in commercializing its intellectual properties in the area of diagnosis and treatment of breast cancer, ALS, Alzheimer's disease and Parkinson's disease. Power3 is seeing a lot of volume today on no new news. It traded today over 7.6 million shares and making share price gains of over 50%. The last news back in September confirmed that the company’s President and CSO, Dr. Ira Goldknopf will give a Keynote address and chair a session on "Biomarkers and Diagnostics in Personalized Medicine" at the BIT Life Sciences 2nd International Congress and Expo of Molecular Diagnostics in Beijing, China, scheduled for November 19th through the 21st. The theme of the meeting is "New Leadership of Personalized Medicine."
DIRECTV Group Inc.
